Recommended in Gynaecologic cancers

Oral contraceptives not a risk factor for cervical cancer
  • Univadis Medical News
  • 1 comment

Oral contraceptives not a risk factor for cervical cancer

Meta-analysis of case-control studies.

Read more
  • Univadis Medical News
  • 1 comment

Manchester attack: visiting health workers among first to offer assistance

Read more
  • Univadis Medical News
  • 1 comment

European medical schools urged to adopt ‘One Health’ approach

Read more
  • Univadis Editorial - Dr Harry Brown
  • 1 comment

Data –a hugely important topic

Read more
  • Univadis Medical News
  • 1 comment

Create a disclosure culture to curb medical errors

Read more
  • Univadis Medical News
  • 1 comment

Patients of older doctors have higher inpatient mortality rates

Read more
  • Univadis Medical News
  • 1 comment

Artificial Intelligence: can data help stop chronic conditions before they start?

Read more
  • Univadis Medical News
  • 1 comment

World Medical Association to host major conferences on physician assisted suicide

Read more
  • Univadis Medical News
  • 1 comment

Almost half of deaths now have recorded cause

Read more

Professional & Business

  • International Medical Press

Elderly care costs set for steep increase, say researchers

Read more
  • International Medical Press

GP numbers fall short of targets

Read more
  • International Medical Press

New GMC standards for postgrad training

Read more
  • International Medical Press

Testing platelet counts could speed up cancer diagnosis

Read more
  • International Medical Press

Proton beam therapy available in UK ‘within the next year’

Read more
  • International Medical Press

Judge criticizes government cuts to community pharmacy

Read more
View more

New in Gynaecologic cancers

  • Clinical Essentials from Gynecol Oncol
  • no comment

High-risk EC: SLN mapping offers alternative to complete LAD

Sentinel lymph node biopsy identified 95% of patients with positive lymph nodes.

Read more
  • Clinical Essentials from FDA
  • 1 comment

FDA greenlights first cancer treatment for any solid tumor sharing a specific biomarker

First go-ahead to treatment based on a shared marker and not originating tissue.

Read more
  • Clinical Essentials from Int J Cancer
  • 1 comment

Cervical cancer: adjuvant CCRT tops chemo for local control

Adding pelvic irradiation to systemic chemotherapy may be indicated for high-risk patients.

Read more
  • Clinical Essentials from Am J Obstet Gynecol.
  • 1 comment

Early cervical adenocarcinoma: no survival benefit for radical surgery

A SEER database analysis.

Read more
  • Clinical Essentials from Strahlenther Onkol.
  • no comment

Cervical cancer: health issues persist in long-term survivors

Study evaluates cancer-specific QoL issues 4 or more y after radiation therapy.

Read more
  • Clinical Essentials from J Turk Ger Gynecol Assoc.
  • 1 comment

Ovarian cancer: platinum-based chemo yields similar outcomes in TTC, EOC

Transitional cell carcinoma is not linked to better prognosis than more common histologic types.

Read more
  • Clinical Essentials from Brachytherapy
  • 1 comment

Early USC: is adjuvant vaginal brachytherapy enough?

Study evaluates survival outcomes across various radiation treatment modalities.

Read more
  • Clinical Essentials from Gynecol Oncol
  • no comment

Vulvar cancer: achieving metrics optimizes RT outcomes in older women

A study of SEER-Medicare linked data.

Read more
  • Clinical Essentials from J Oncol Pract
  • 1 comment

Study supports illegal darbepoetin marketing claim

Settlements, fines, and repayments have amounted to $1.1 billion.

Read more
  • Clinical Essentials from Prev Med
  • 1 comment

HPV screening rates suboptimal among women in the US

Rates are dropping among women aged 21-65 y.

Read more
  • Univadis Editorial - Dr Harry Brown
  • 1 comment

Promises galore

What health-related promises are on offer from the various political parties?

Read more
Avoid these words when speaking to patients
  • Univadis Medical News
  • 1 comment

Avoid these words when speaking to patients

Using language with negative emotional content may lead to an increase in the patient’s experience of pain or anxiety.

Read more
  • Clinical Essentials from Ann Oncol
  • 1 comment

Platinum-reistant ovarian cancer: bevacizumab boosts OS

Phase 3 Aurelia data show benefit with chemotherapy, or on progression after chemotherapy.

Read more
  • Clinical Essentials from Int J Gynecol Cancer
  • 1 comment

Endometrial cancer: post-RT adjuvant chemotherapy prolongs survival

Study of patients with early-stage high-risk disease.

Read more